Respiratory virus season is only starting, and demand has already outstripped supply for the newly approved and potentially lifesaving monoclonal antibody injection for preventing respiratory syncytial virus (RSV) in...
An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these...
While Paxlovid remains a ‘life-saving drug,’ Mass General Brigham researchers found that patients experiencing virologic rebound after treatment may remain contagious A new study by investigators from Mass General...
Part 6 of the series on COVID-19 presented by Prof. Catherine Weil-Olivier, and Prof. Joe Schmitt.
This Global Health Cast was produced with the unconditional support of an educational grant from Novavax ().
A report in the journal Health Affairs has found that proof-of-vaccine mandates may be an effective way to increase vaccination uptake across certain age groups, after studying the policy enforced during the COVID-19...
Babies born to mothers who received a Covid-19 vaccine during their pregnancy were significantly protected against the disease in their first six months of life, according to a local study by a team led by KK Women’s...
Nipah virus (NiV) is an emerging zoonotic virus that has caused outbreaks of severe illness and death in the South-East (SE) Asia Region. While human NiV cases have, to date, been reported only in Bangladesh and India...
Four years since the first children received the world’s first malaria vaccine as part of routine immunisation programmes, important questions about the real-world impact of the RTS,S/AS01 malaria vaccine are being...